Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 5, 2011, Pages 702-709

  Huang, Zhi Liang ^a,b   Luo, Jun ^a,b   Chen, Min Shan ^a,b   Li, Jin Qing ^a,b   Shi, Ming ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

fetoprotein; AFP; C reactive protein; CRP; HCC; hepatocellular carcinoma; IL; interleukin; neutrophil to lymphocyte ratio; NLR; prothrombin time; PT

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; EPIRUBICIN; GELFOAM; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL TO LYMPHOCYTE RATIO; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVAL TIME; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955370187     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.12.041     Document Type: Article

References (32)

1. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917 (Pubitemid 37518510)
2. P. Rougier, E. Mitry, J.C. Barbare, and J. Taieb Hepatocellular carcinoma (HCC): an update Semin Oncol 34 2 Suppl 1 2007 S12 s20
3. D.C. McMillan, K. Canna, and C.S. McArdle Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 2003 215 219 (Pubitemid 36237897)
4. R. Zahorec Ratio of neutrophil to lymphocyte countsrapid and simple parameter of systemic inflammation and stress in critically ill Bratisl Lek Listy 102 2001 5 14
5. D. Gomez, S. Farid, and H.Z. Malik Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
6. E.J. Cook, S.R. Walsh, N. Farooq, J.C. Alberts, T.A. Justin, and N.J. Keeling Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery Int J Surg 5 2007 27 30 (Pubitemid 46330184)
7. B.K. Duffy, H.S. Gurm, V. Rajagopal, R. Gupta, S.G. Ellis, and D.L. Bhatt Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention Am J Cardiol 97 2006 993 996
8. M. Aliustaoglu, A. Bilici, and B.B. Ustaalioglu The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment Med Oncol 27 2010 1060 1065
9. H. Cho, H.W. Hur, and S.W. Kim Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 2009 15 23
10. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, and N.J. Keeling Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184 (Pubitemid 41254421)
11. K.J. Halazun, A. Aldoori, and H.Z. Malik Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases Eur J Surg Oncol 34 2008 55 60 (Pubitemid 350296756)
12. Y. Kishi, S. Kopetz, Y.S. Chun, M. Palavecino, E.K. Abdalla, and J.N. Vauthey Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol 16 2009 614 622
13. Z.X. Guo, W. Wei, C. Zhong, M. Shi, M.S. Chen, and R.P. Guo Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma Chin J Cancer 28 2009 1203 1208
14. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430 (Pubitemid 32844200)
15. M. Shi, J.A. Chen, and X.J. Lin Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China World J Gastroenterol 16 2010 264 269
16. H. Kasugai, J. Kojima, and M. Tatsuta Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil Gastroenterology 97 1989 965 971 (Pubitemid 19239037)
17. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545 (Pubitemid 32173595)
18. Y. Wada, O. Nakashima, R. Kutami, O. Yamamoto, and M. Kojiro Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Hepatology 27 1998 407 414 (Pubitemid 28081054)
19. J. Galon, A. Costes, and F. Sanchez-Cabo Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964 (Pubitemid 44498003)
20. Y. Naito, K. Saito, and K. Shiiba CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 1998 3491 3494 (Pubitemid 28376536)
21. I. Ray-Coquard, C. Cropet, and M. Van Glabbeke Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas Cancer Res 69 2009 5383 5391
22. Y. Gong, and D.R. Koh Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model Cell Tissue Res 339 2010 437 448
23. Y.H. Kusumanto, W.A. Dam, G.A. Hospers, C. Meijer, and N.H. Mulder Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor Angiogenesis 6 2003 283 287 (Pubitemid 38987537)
24. P.E. Neagoe, A. Brkovic, F. Hajjar, and M.G. Sirois Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms Growth Factors 27 2009 335 344
25. L.M. Coussens, C.L. Tinkle, D. Hanahan, and Z. Werb MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
26. C. Zhong, R.P. Guo, M. Shi, W. Wei, W.S. Yu, and J.Q. Li Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma Chin J Cancer 25 2006 599 603
27. R. Yamaguchi, H. Yano, and O. Nakashima Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma J Gastroenterol Hepatol 21 2006 152 160
28. L.X. Qin, and Z.Y. Tang The prognostic molecular markers in hepatocellular carcinoma World J Gastroenterol 8 2002 385 392
29. A. Zerbini, M. Pilli, and D. Laccabue Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response Gastroenterology 138 2010 1931 1942
30. F. Rashid, N. Waraich, and I. Bhatti A pre-operative elevated neutrophil:lymphocyte ratio does not predict survival from oesophageal cancer resection World J Surg Oncol 8 2010 1
31. P. Scapini, J.A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M.A. Cassatella The neutrophil as a cellular source of chemokines Immunol Rev 177 2000 195 203
32. A.M. Hicks, G. Riedlinger, and M.C. Willingham Transferable anticancer innate immunity in spontaneous regression/complete resistance mice Proc Natl Acad Sci U S A 103 2006 7753 7758